Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues

BACKGROUND: Adoptive immunotherapy offers great potential for treating many types of cancer but its clinical application is hampered by cross-reactive T cell responses in healthy human tissues, representing serious safety risks for patients. We previously developed a computational tool called Expito...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaravine, Victor, Mösch, Anja, Raffegerst, Silke, Schendel, Dolores J., Frishman, Dmitrij
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Software
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745885/
https://www.ncbi.nlm.nih.gov/pubmed/29282079
http://dx.doi.org/10.1186/s12885-017-3854-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745885/
https://www.ncbi.nlm.nih.gov/pubmed/29282079
http://dx.doi.org/10.1186/s12885-017-3854-8

Ejemplares similares